The invention relates to a high-barrier multilayer co-
extrusion infusion film which is a five-layer
composite film with the composition from the outer layer to the inner layer:
polyethylene naphthalate modified
polyester /
ethylene acrylic acid polymer /
polypropylene,
ethylene- octylene
copolymer blending resin /
ethylene propylene
polymer / modified
polypropylene. The advantages of various functional
polymer materials are combined by the high-barrier multilayer co-
extrusion infusion film, so that not only are the light
transmittance, the flexibility, the high barrier performance, the low-temperature thermal sealing property, the
thermal bonding strength and the like of the high-barrier multilayer co-
extrusion infusion film guaranteed, but also the high-temperature-resistant (121 DEG C and 30min) sterilization performance and the low-temperature-resistant (-30 DEG C) storage performance of the high-barrier multilayer co-extrusion infusion film can be improved; therefore, the matters (including nonvolatile matter, easily-oxidized matter, heavy
metal and the like) dissolved out from the infusion film are fewer, a biological or
chemical reaction is not caused between the infusion film and liquid
medicine after filling sterilization, and
toxin is not generated or environmental
pollution is not caused when the infusion film is produced, used and recovered. Compared with other similar products, the high-barrier multilayer co-extrusion infusion film has excellent competitive advantages in the aspect of all technical indexes such as production formula, production technique and performances.